RBM10とは？ わかりやすく解説

Weblio 辞書 > 辞書・百科事典 > 百科事典 > RBM10の意味・解説 
ウィキペディア
索引トップ ランキング カテゴリー
ウィキペディアウィキペディア

RBM10

(RNA-binding motif 10 から転送)

出典: フリー百科事典『ウィキペディア（Wikipedia）』 (2022/08/28 07:09 UTC 版)

RBM10（RNA-binding motif 10）はRBM10遺伝子にコードされたタンパク質[5][6][7][8]。ヒトの遺伝子はX染色体上のXp11.23に位置する。RBM10は選択的スプライシングを調節する因子である[9][10][11]。選択的スプライシングは転写後のpre-mRNAに作動して単一遺伝子から複数のタンパク質アイソフォームを生成する遺伝子発現の調節機構であり、細胞に機能的多様性と複雑性を作り出す[12]。RBM10は多数の遺伝子の発現に組み込まれ[9][10][13][14][15]、細胞増殖やアポトーシスなどさまざまな細胞過程に関与する[10][16]。RBM10遺伝子の変異は、出生前後に多くが致死となるX連鎖型先天異常のTARP症候群を引き起こし、成人でのさまざまながんなどの疾病に関わる[17][18][19][20][21][22]。


出典
  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000182872 - Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000031060 - Ensembl, May 2017
  3. ^ Human PubMed Reference:
  4. ^ Mouse PubMed Reference:
  5. ^ Nagase, T.; Seki, N.; Tanaka, A.; Ishikawa, K.; Nomura, N. (1995-08-31). “Prediction of the coding sequences of unidentified human genes. IV. The coding sequences of 40 new genes (KIAA0121-KIAA0160) deduced by analysis of cDNA clones from human cell line KG-1”. DNA research: an international journal for rapid publication of reports on genes and genomes 2 (4): 167–174, 199–210. doi:10.1093/dnares/2.4.167. ISSN 1340-2838. PMID 8590280. https://pubmed.ncbi.nlm.nih.gov/8590280. 
  6. ^ a b c Coleman, M. P.; Ambrose, H. J.; Carrel, L.; Németh, A. H.; Willard, H. F.; Davies, K. E. (1996-01-01). “A novel gene, DXS8237E, lies within 20 kb upstream of UBE1 in Xp11.23 and has a different X inactivation status”. Genomics 31 (1): 135–138. doi:10.1006/geno.1996.0022. ISSN 0888-7543. PMID 8808293. https://pubmed.ncbi.nlm.nih.gov/8808293. 
  7. ^ a b c Thiselton, Dawn L.; McDowall, Jennifer; Brandau, Oliver; Ramser, Juliane; d'Esposito, Fabiana; Bhattacharya, Shomi S.; Ross, Mark T.; Hardcastle, Alison J. et al. (2002-04). “An integrated, functionally annotated gene map of the DXS8026-ELK1 interval on human Xp11.3-Xp11.23: potential hotspot for neurogenetic disorders”. Genomics 79 (4): 560–572. doi:10.1006/geno.2002.6733. ISSN 0888-7543. PMID 11944989. https://pubmed.ncbi.nlm.nih.gov/11944989. 
  8. ^ Inoue, A.; Takahashi, K. P.; Kimura, M.; Watanabe, T.; Morisawa, S. (1996-08-01). “Molecular cloning of a RNA binding protein, S1-1”. Nucleic Acids Research 24 (15): 2990–2997. doi:10.1093/nar/24.15.2990. ISSN 0305-1048. PMC PMC146028. PMID 8760884. https://pubmed.ncbi.nlm.nih.gov/8760884. 
  9. ^ a b c d e f Wang, Yongbo; Gogol-Döring, Andreas; Hu, Hao; Fröhler, Sebastian; Ma, Yunxia; Jens, Marvin; Maaskola, Jonas; Murakawa, Yasuhiro et al. (2013-09). “Integrative analysis revealed the molecular mechanism underlying RBM10-mediated splicing regulation”. EMBO molecular medicine 5 (9): 1431–1442. doi:10.1002/emmm.201302663. ISSN 1757-4684. PMC 3799496. PMID 24000153. https://pubmed.ncbi.nlm.nih.gov/24000153. 
  10. ^ a b c d e f g h i j k l Bechara, Elias G.; Sebestyén, Endre; Bernardis, Isabella; Eyras, Eduardo; Valcárcel, Juan (2013-12-12). “RBM5, 6, and 10 differentially regulate NUMB alternative splicing to control cancer cell proliferation”. Molecular Cell 52 (5): 720–733. doi:10.1016/j.molcel.2013.11.010. ISSN 1097-4164. PMID 24332178. https://pubmed.ncbi.nlm.nih.gov/24332178. 
  11. ^ a b Inoue, Akira; Yamamoto, Naoki; Kimura, Masatsugu; Nishio, Koji; Yamane, Hideo; Nakajima, Koichi (2014-03-18). “RBM10 regulates alternative splicing”. FEBS letters 588 (6): 942–947. doi:10.1016/j.febslet.2014.01.052. ISSN 1873-3468. PMID 24530524. https://pubmed.ncbi.nlm.nih.gov/24530524. 
  12. ^ Yang, Xinping; Coulombe-Huntington, Jasmin; Kang, Shuli; Sheynkman, Gloria M.; Hao, Tong; Richardson, Aaron; Sun, Song; Yang, Fan et al. (2016-02-11). “Widespread Expansion of Protein Interaction Capabilities by Alternative Splicing”. Cell 164 (4): 805–817. doi:10.1016/j.cell.2016.01.029. ISSN 1097-4172. PMC 4882190. PMID 26871637. https://pubmed.ncbi.nlm.nih.gov/26871637. 
  13. ^ Sutherland, Leslie C.; Thibault, Philippe; Durand, Mathieu; Lapointe, Elvy; Knee, Jose M.; Beauvais, Ariane; Kalatskaya, Irina; Hunt, Sarah C. et al. (07 20, 2017). “Splicing arrays reveal novel RBM10 targets, including SMN2 pre-mRNA”. BMC molecular biology 18 (1): 19. doi:10.1186/s12867-017-0096-x. ISSN 1471-2199. PMC 5520337. PMID 28728573. https://pubmed.ncbi.nlm.nih.gov/28728573. 
  14. ^ a b c d Sun, Yue; Bao, Yufang; Han, Wenjian; Song, Fan; Shen, Xianfeng; Zhao, Jiawei; Zuo, Ji; Saffen, David et al. (2017-08-21). “Autoregulation of RBM10 and cross-regulation of RBM10/RBM5 via alternative splicing-coupled nonsense-mediated decay”. Nucleic Acids Research 45 (14): 8524–8540. doi:10.1093/nar/gkx508. ISSN 1362-4962. PMC 5737846. PMID 28586478. https://pubmed.ncbi.nlm.nih.gov/28586478. 
  15. ^ Collins, Katherine M.; Kainov, Yaroslav A.; Christodolou, Evangelos; Ray, Debashish; Morris, Quaid; Hughes, Timothy; Taylor, Ian A.; Makeyev, Eugene V. et al. (2017-06-20). “An RRM-ZnF RNA recognition module targets RBM10 to exonic sequences to promote exon exclusion”. Nucleic Acids Research 45 (11): 6761–6774. doi:10.1093/nar/gkx225. ISSN 1362-4962. PMC 5499739. PMID 28379442. https://pubmed.ncbi.nlm.nih.gov/28379442. 
  16. ^ a b c Loiselle, Julie J.; Roy, Justin G.; Sutherland, Leslie C. (2017). “RBM10 promotes transformation-associated processes in small cell lung cancer and is directly regulated by RBM5”. PloS One 12 (6): e0180258. doi:10.1371/journal.pone.0180258. ISSN 1932-6203. PMC 5491171. PMID 28662214. https://pubmed.ncbi.nlm.nih.gov/28662214. 
  17. ^ a b c Johnston, Jennifer J.; Teer, Jamie K.; Cherukuri, Praveen F.; Hansen, Nancy F.; Loftus, Stacie K.; NIH Intramural Sequencing Center (NISC); Chong, Karen; Mullikin, James C. et al. (2010-05-14). “Massively parallel sequencing of exons on the X chromosome identifies RBM10 as the gene that causes a syndromic form of cleft palate”. American Journal of Human Genetics 86 (5): 743–748. doi:10.1016/j.ajhg.2010.04.007. ISSN 1537-6605. PMC 2868995. PMID 20451169. https://pubmed.ncbi.nlm.nih.gov/20451169. 
  18. ^ a b Gorlin, R. J.; Cervenka, J.; Anderson, R. C.; Sauk, J. J.; Bevis, W. D. (1970-02). “Robin's syndrome. A probably X-linked recessive subvariety exhibiting persistence of left superior vena cava and atrial septal defect”. American Journal of Diseases of Children (1960) 119 (2): 176–178. ISSN 0002-922X. PMID 5410571. https://pubmed.ncbi.nlm.nih.gov/5410571. 
  19. ^ a b Imielinski, Marcin; Berger, Alice H.; Hammerman, Peter S.; Hernandez, Bryan; Pugh, Trevor J.; Hodis, Eran; Cho, Jeonghee; Suh, James et al. (2012-09-14). “Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing”. Cell 150 (6): 1107–1120. doi:10.1016/j.cell.2012.08.029. ISSN 1097-4172. PMC 3557932. PMID 22980975. https://pubmed.ncbi.nlm.nih.gov/22980975. 
  20. ^ a b Seiler, Michael; Peng, Shouyong; Agrawal, Anant A.; Palacino, James; Teng, Teng; Zhu, Ping; Smith, Peter G.; Cancer Genome Atlas Research Network et al. (04 03, 2018). “Somatic Mutational Landscape of Splicing Factor Genes and Their Functional Consequences across 33 Cancer Types”. Cell Reports 23 (1): 282–296.e4. doi:10.1016/j.celrep.2018.01.088. ISSN 2211-1247. PMC 5933844. PMID 29617667. https://pubmed.ncbi.nlm.nih.gov/29617667. 
  21. ^ a b Cieply, Benjamin; Carstens, Russ P. (2015-05). “Functional roles of alternative splicing factors in human disease”. Wiley interdisciplinary reviews. RNA 6 (3): 311–326. doi:10.1002/wrna.1276. ISSN 1757-7012. PMC 4671264. PMID 25630614. https://pubmed.ncbi.nlm.nih.gov/25630614. 
  22. ^ a b Coomer, Alice O.; Black, Fiona; Greystoke, Alastair; Munkley, Jennifer; Elliott, David J. (2019-11). “Alternative splicing in lung cancer”. Biochimica Et Biophysica Acta. Gene Regulatory Mechanisms 1862 (11-12): 194388. doi:10.1016/j.bbagrm.2019.05.006. ISSN 1876-4320. PMID 31152916. https://pubmed.ncbi.nlm.nih.gov/31152916. 
  23. ^ a b Rodor, Julie; FitzPatrick, David R.; Eyras, Eduardo; Cáceres, Javier F. (01 02, 2017). “The RNA-binding landscape of RBM10 and its role in alternative splicing regulation in models of mouse early development”. RNA biology 14 (1): 45–57. doi:10.1080/15476286.2016.1247148. ISSN 1555-8584. PMC 5270529. PMID 27763814. https://pubmed.ncbi.nlm.nih.gov/27763814. 
  24. ^ “RBM10 RNA binding motif protein 10 [Homo sapiens (human) - Gene - NCBI]”. www.ncbi.nlm.nih.gov. 2020年12月5日閲覧。
  25. ^ a b c d e Inoue, Akira; Tsugawa, Katsuji; Tokunaga, Kazuaki; Takahashi, Kenichi P.; Uni, Shigehiko; Kimura, Masatsugu; Nishio, Koji; Yamamoto, Naoki et al. (2008-09). “S1-1 nuclear domains: characterization and dynamics as a function of transcriptional activity”. Biology of the Cell 100 (9): 523–535. doi:10.1042/BC20070142. ISSN 1768-322X. PMID 18315527. https://pubmed.ncbi.nlm.nih.gov/18315527. 
  26. ^ a b Zheng, Sika; Damoiseaux, Robert; Chen, Liang; Black, Douglas L. (2013-06). “A broadly applicable high-throughput screening strategy identifies new regulators of Dlg4 (Psd-95) alternative splicing”. Genome Research 23 (6): 998–1007. doi:10.1101/gr.147546.112. ISSN 1549-5469. PMC 3668367. PMID 23636947. https://pubmed.ncbi.nlm.nih.gov/23636947. 
  27. ^ Lim, Janghoo; Hao, Tong; Shaw, Chad; Patel, Akash J.; Szabó, Gábor; Rual, Jean-François; Fisk, C. Joseph; Li, Ning et al. (2006-05-19). “A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration”. Cell 125 (4): 801–814. doi:10.1016/j.cell.2006.03.032. ISSN 0092-8674. PMID 16713569. https://pubmed.ncbi.nlm.nih.gov/16713569. 
  28. ^ Mohan, Nimmy; Kumar, Vikas; Kandala, Divya T.; Kartha, Chandrasekharan C.; Laishram, Rakesh S. (09 25, 2018). “A Splicing-Independent Function of RBM10 Controls Specific 3' UTR Processing to Regulate Cardiac Hypertrophy”. Cell Reports 24 (13): 3539–3553. doi:10.1016/j.celrep.2018.08.077. ISSN 2211-1247. PMID 30257214. https://pubmed.ncbi.nlm.nih.gov/30257214. 
  29. ^ a b c Mueller, Cornelius F. H.; Berger, Anja; Zimmer, Sebastian; Tiyerili, Vedat; Nickenig, Georg (2009-08-01). “The heterogenous nuclear riboprotein S1-1 regulates AT1 receptor gene expression via transcriptional and posttranscriptional mechanisms”. Archives of Biochemistry and Biophysics 488 (1): 76–82. doi:10.1016/j.abb.2009.06.002. ISSN 1096-0384. PMID 19508861. https://pubmed.ncbi.nlm.nih.gov/19508861. 
  30. ^ Treiber, Thomas; Treiber, Nora; Plessmann, Uwe; Harlander, Simone; Daiß, Julia-Lisa; Eichner, Norbert; Lehmann, Gerhard; Schall, Kevin et al. (2017-04-20). “A Compendium of RNA-Binding Proteins that Regulate MicroRNA Biogenesis”. Molecular Cell 66 (2): 270–284.e13. doi:10.1016/j.molcel.2017.03.014. ISSN 1097-4164. PMID 28431233. https://pubmed.ncbi.nlm.nih.gov/28431233. 
  31. ^ a b c Jung, Ji Hoon; Lee, Hyemin; Cao, Bo; Liao, Peng; Zeng, Shelya X.; Lu, Hua (01 2020). “RNA-binding motif protein 10 induces apoptosis and suppresses proliferation by activating p53”. Oncogene 39 (5): 1031–1040. doi:10.1038/s41388-019-1034-9. ISSN 1476-5594. PMC 6994357. PMID 31591476. https://pubmed.ncbi.nlm.nih.gov/31591476. 
  32. ^ Guan, Guofang; Li, Ranwei; Tang, Wenfang; Liu, Tiecheng; Su, Zhenzhong; Wang, Yan; Tan, Jingjin; Jiang, Shan et al. (2017-03). “Expression of RNA-binding motif 10 is associated with advanced tumor stage and malignant behaviors of lung adenocarcinoma cancer cells”. Tumour Biology: The Journal of the International Society for Oncodevelopmental Biology and Medicine 39 (3): 1010428317691740. doi:10.1177/1010428317691740. ISSN 1423-0380. PMID 28347232. https://pubmed.ncbi.nlm.nih.gov/28347232. 
  33. ^ Kunimoto, Hiroyuki; Inoue, Akira; Kojima, Hirotada; Yang, Junhao; Zhao, Hong; Tsuruta, Daisuke; Nakajima, Koichi (2020-02). “RBM10 regulates centriole duplication in HepG2 cells by ectopically assembling PLK4-STIL complexes in the nucleus”. Genes to Cells: Devoted to Molecular & Cellular Mechanisms 25 (2): 100–110. doi:10.1111/gtc.12741. ISSN 1365-2443. PMID 31820547. https://pubmed.ncbi.nlm.nih.gov/31820547. 
  34. ^ Pozzi, Berta; Bragado, Laureano; Mammi, Pablo; Torti, María Florencia; Gaioli, Nicolás; Gebhard, Leopoldo G.; García Solá, Martín E.; Vaz-Drago, Rita et al. (07 09, 2020). “Dengue virus targets RBM10 deregulating host cell splicing and innate immune response”. Nucleic Acids Research 48 (12): 6824–6838. doi:10.1093/nar/gkaa340. ISSN 1362-4962. PMC 7337517. PMID 32432721. https://pubmed.ncbi.nlm.nih.gov/32432721. 
  35. ^ Salichs, Eulàlia; Ledda, Alice; Mularoni, Loris; Albà, M. Mar; de la Luna, Susana (2009-03). “Genome-wide analysis of histidine repeats reveals their role in the localization of human proteins to the nuclear speckles compartment”. PLoS genetics 5 (3): e1000397. doi:10.1371/journal.pgen.1000397. ISSN 1553-7404. PMC 2644819. PMID 19266028. https://pubmed.ncbi.nlm.nih.gov/19266028. 
  36. ^ Goto, Yuji; Kimura, Hiroshi (2009-12). “Inactive X chromosome-specific histone H3 modifications and CpG hypomethylation flank a chromatin boundary between an X-inactivated and an escape gene”. Nucleic Acids Research 37 (22): 7416–7428. doi:10.1093/nar/gkp860. ISSN 0305-1048. PMC 2794193. PMID 19843608. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2794193/. 
  37. ^ Stes, Elisabeth; Laga, Mathias; Walton, Alan; Samyn, Noortje; Timmerman, Evy; De Smet, Ive; Goormachtig, Sofie; Gevaert, Kris (2014-06-06). “A COFRADIC protocol to study protein ubiquitination”. Journal of Proteome Research 13 (6): 3107–3113. doi:10.1021/pr4012443. ISSN 1535-3907. PMID 24816145. https://pubmed.ncbi.nlm.nih.gov/24816145. 
  38. ^ Akimov, Vyacheslav; Barrio-Hernandez, Inigo; Hansen, Sten V. F.; Hallenborg, Philip; Pedersen, Anna-Kathrine; Bekker-Jensen, Dorte B.; Puglia, Michele; Christensen, Stine D. K. et al. (07 2018). “UbiSite approach for comprehensive mapping of lysine and N-terminal ubiquitination sites”. Nature Structural & Molecular Biology 25 (7): 631–640. doi:10.1038/s41594-018-0084-y. ISSN 1545-9985. PMID 29967540. https://pubmed.ncbi.nlm.nih.gov/29967540. 
  39. ^ Choudhary, Chunaram; Kumar, Chanchal; Gnad, Florian; Nielsen, Michael L.; Rehman, Michael; Walther, Tobias C.; Olsen, Jesper V.; Mann, Matthias (2009-08-14). “Lysine acetylation targets protein complexes and co-regulates major cellular functions”. Science (New York, N.Y.) 325 (5942): 834–840. doi:10.1126/science.1175371. ISSN 1095-9203. PMID 19608861. https://pubmed.ncbi.nlm.nih.gov/19608861. 
  40. ^ Guo, Ailan; Gu, Hongbo; Zhou, Jing; Mulhern, Daniel; Wang, Yi; Lee, Kimberly A.; Yang, Vicky; Aguiar, Mike et al. (2014-01). “Immunoaffinity enrichment and mass spectrometry analysis of protein methylation”. Molecular & cellular proteomics: MCP 13 (1): 372–387. doi:10.1074/mcp.O113.027870. ISSN 1535-9484. PMC 3879628. PMID 24129315. https://pubmed.ncbi.nlm.nih.gov/24129315. 
  41. ^ Cancer Genome Atlas Research Network (2014-07-31). “Comprehensive molecular profiling of lung adenocarcinoma”. Nature 511 (7511): 543–550. doi:10.1038/nature13385. ISSN 1476-4687. PMC 4231481. PMID 25079552. https://pubmed.ncbi.nlm.nih.gov/25079552. 
  42. ^ Yuan, Yuan; Liu, Lingxiang; Chen, Hu; Wang, Yumeng; Xu, Yanxun; Mao, Huzhang; Li, Jun; Mills, Gordon B. et al. (05 09, 2016). “Comprehensive Characterization of Molecular Differences in Cancer between Male and Female Patients”. Cancer Cell 29 (5): 711–722. doi:10.1016/j.ccell.2016.04.001. ISSN 1878-3686. PMC 4864951. PMID 27165743. https://pubmed.ncbi.nlm.nih.gov/27165743. 
  43. ^ Yin, Lin-Lin; Wen, Xin-Mian; Li, Ming; Xu, Yan-Mei; Zhao, Xiao-Feng; Li, Jing; Wang, Xiu-Wen (2018-11). “A gene mutation in RNA-binding protein 10 is associated with lung adenocarcinoma progression and poor prognosis”. Oncology Letters 16 (5): 6283–6292. doi:10.3892/ol.2018.9496. ISSN 1792-1074. PMC 6202477. PMID 30405763. https://pubmed.ncbi.nlm.nih.gov/30405763. 
  44. ^ Powis, Zöe; Hart, Alexa; Cherny, Sara; Petrik, Igor; Palmaer, Erika; Tang, Sha; Jones, Carolyn (06 02, 2017). “Clinical diagnostic exome evaluation for an infant with a lethal disorder: genetic diagnosis of TARP syndrome and expansion of the phenotype in a patient with a newly reported RBM10 alteration”. BMC medical genetics 18 (1): 60. doi:10.1186/s12881-017-0426-3. ISSN 1471-2350. PMC 5455125. PMID 28577551. https://pubmed.ncbi.nlm.nih.gov/28577551. 
  45. ^ Gripp, Karen W.; Hopkins, Elizabeth; Johnston, Jennifer J.; Krause, Caitlin; Dobyns, William B.; Biesecker, Leslie G. (2011-10). “Long-term survival in TARP syndrome and confirmation of RBM10 as the disease-causing gene”. American Journal of Medical Genetics. Part A 155A (10): 2516–2520. doi:10.1002/ajmg.a.34190. ISSN 1552-4833. PMC 3183328. PMID 21910224. https://pubmed.ncbi.nlm.nih.gov/21910224. 
  46. ^ Niceta, Marcello; Barresi, Sabina; Pantaleoni, Francesca; Capolino, Rossella; Dentici, Maria Lisa; Ciolfi, Andrea; Pizzi, Simone; Bartuli, Andrea et al. (2019-06). “TARP syndrome: Long-term survival, anatomic patterns of congenital heart defects, differential diagnosis and pathogenetic considerations”. European Journal of Medical Genetics 62 (6): 103534. doi:10.1016/j.ejmg.2018.09.001. ISSN 1878-0849. PMID 30189253. https://pubmed.ncbi.nlm.nih.gov/30189253. 
  47. ^ Højland, Allan T.; Lolas, Ihab; Okkels, Henrik; Lautrup, Charlotte K.; Diness, Birgitte R.; Petersen, Michael B.; Nielsen, Irene K. (12 2018). “First reported adult patient with TARP syndrome: A case report”. American Journal of Medical Genetics. Part A 176 (12): 2915–2918. doi:10.1002/ajmg.a.40638. ISSN 1552-4833. PMC 6587983. PMID 30462380. https://pubmed.ncbi.nlm.nih.gov/30462380. 
  48. ^ Xia, Qiu-Yuan; Wang, Xiao-Tong; Zhan, Xue-Mei; Tan, Xiao; Chen, Hao; Liu, Yi; Shi, Shan-Shan; Wang, Xuan et al. (2017-05). “Xp11 Translocation Renal Cell Carcinomas (RCCs) With RBM10-TFE3 Gene Fusion Demonstrating Melanotic Features and Overlapping Morphology With t(6;11) RCC: Interest and Diagnostic Pitfall in Detecting a Paracentric Inversion of TFE3”. The American Journal of Surgical Pathology 41 (5): 663–676. doi:10.1097/PAS.0000000000000837. ISSN 1532-0979. PMID 28288037. https://pubmed.ncbi.nlm.nih.gov/28288037. 
  49. ^ Argani, Pedram; Zhang, Lei; Reuter, Victor E.; Tickoo, Satish K.; Antonescu, Cristina R. (2017-05). “RBM10-TFE3 Renal Cell Carcinoma: A Potential Diagnostic Pitfall Due to Cryptic Intrachromosomal Xp11.2 Inversion Resulting in False-negative TFE3 FISH”. The American Journal of Surgical Pathology 41 (5): 655–662. doi:10.1097/PAS.0000000000000835. ISSN 1532-0979. PMC 5391276. PMID 28296677. https://pubmed.ncbi.nlm.nih.gov/28296677. 
  50. ^ Kato, Ikuma; Furuya, Mitsuko; Baba, Masaya; Kameda, Yoichi; Yasuda, Masanori; Nishimoto, Koshiro; Oyama, Masafumi; Yamasaki, Toshinari et al. (2019-08). “RBM10-TFE3 renal cell carcinoma characterised by paracentric inversion with consistent closely split signals in break-apart fluorescence in-situ hybridisation: study of 10 cases and a literature review”. Histopathology 75 (2): 254–265. doi:10.1111/his.13866. ISSN 1365-2559. PMID 30908700. https://pubmed.ncbi.nlm.nih.gov/30908700. 
  51. ^ a b Witkiewicz, Agnieszka K.; McMillan, Elizabeth A.; Balaji, Uthra; Baek, GuemHee; Lin, Wan-Chi; Mansour, John; Mollaee, Mehri; Wagner, Kay-Uwe et al. (2015-04-09). “Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets”. Nature Communications 6: 6744. doi:10.1038/ncomms7744. ISSN 2041-1723. PMC 4403382. PMID 25855536. https://pubmed.ncbi.nlm.nih.gov/25855536. 
  52. ^ Furukawa, Toru; Kuboki, Yuko; Tanji, Etsuko; Yoshida, Shoko; Hatori, Takashi; Yamamoto, Masakazu; Shibata, Noriyuki; Shimizu, Kyoko et al. (2011). “Whole-exome sequencing uncovers frequent GNAS mutations in intraductal papillary mucinous neoplasms of the pancreas”. Scientific Reports 1: 161. doi:10.1038/srep00161. ISSN 2045-2322. PMC 3240977. PMID 22355676. https://pubmed.ncbi.nlm.nih.gov/22355676. 
  53. ^ Giannakis, Marios; Mu, Xinmeng Jasmine; Shukla, Sachet A.; Qian, Zhi Rong; Cohen, Ofir; Nishihara, Reiko; Bahl, Samira; Cao, Yin et al. (2016-04-26). “Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma”. Cell Reports 15 (4): 857–865. doi:10.1016/j.celrep.2016.03.075. ISSN 2211-1247. PMC 4850357. PMID 27149842. https://pubmed.ncbi.nlm.nih.gov/27149842. 
  54. ^ Lawrence, Michael S.; Stojanov, Petar; Mermel, Craig H.; Robinson, James T.; Garraway, Levi A.; Golub, Todd R.; Meyerson, Matthew; Gabriel, Stacey B. et al. (2014-01-23). “Discovery and saturation analysis of cancer genes across 21 tumour types”. Nature 505 (7484): 495–501. doi:10.1038/nature12912. ISSN 1476-4687. PMC 4048962. PMID 24390350. https://pubmed.ncbi.nlm.nih.gov/24390350. 
  55. ^ Ibrahimpasic, Tihana; Xu, Bin; Landa, Iñigo; Dogan, Snjezana; Middha, Sumit; Seshan, Venkatraman; Deraje, Shyam; Carlson, Diane L. et al. (2017-10-01). “Genomic Alterations in Fatal Forms of Non-Anaplastic Thyroid Cancer: Identification of MED12 and RBM10 as Novel Thyroid Cancer Genes Associated with Tumor Virulence”. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 23 (19): 5970–5980. doi:10.1158/1078-0432.CCR-17-1183. ISSN 1078-0432. PMC 5626586. PMID 28634282. https://pubmed.ncbi.nlm.nih.gov/28634282. 
  56. ^ Antonello, Zeus A.; Hsu, Nancy; Bhasin, Manoj; Roti, Giovanni; Joshi, Mukta; Van Hummelen, Paul; Ye, Emily; Lo, Agnes S. et al. (2017-10-17). “Vemurafenib-resistance via de novo RBM genes mutations and chromosome 5 aberrations is overcome by combined therapy with palbociclib in thyroid carcinoma with BRAFV600E”. Oncotarget 8 (49): 84743–84760. doi:10.18632/oncotarget.21262. ISSN 1949-2553. PMC 5689570. PMID 29156680. https://pubmed.ncbi.nlm.nih.gov/29156680. 
  57. ^ Ibrahimpasic, Tihana; Ghossein, Ronald; Shah, Jatin P.; Ganly, Ian (03 2019). “Poorly Differentiated Carcinoma of the Thyroid Gland: Current Status and Future Prospects”. Thyroid: Official Journal of the American Thyroid Association 29 (3): 311–321. doi:10.1089/thy.2018.0509. ISSN 1557-9077. PMC 6437626. PMID 30747050. https://pubmed.ncbi.nlm.nih.gov/30747050. 
  58. ^ a b Kan, Zhengyan; Jaiswal, Bijay S.; Stinson, Jeremy; Janakiraman, Vasantharajan; Bhatt, Deepali; Stern, Howard M.; Yue, Peng; Haverty, Peter M. et al. (2010-08-12). “Diverse somatic mutation patterns and pathway alterations in human cancers”. Nature 466 (7308): 869–873. doi:10.1038/nature09208. ISSN 1476-4687. PMID 20668451. https://pubmed.ncbi.nlm.nih.gov/20668451. 
  59. ^ Tian, Weijun; Hu, Weiyu; Shi, Xiaoling; Liu, Peng; Ma, Xiang; Zhao, Wei; Qu, Linlin; Zhang, Shuirong et al. (2020-04). “Comprehensive genomic profile of cholangiocarcinomas in China”. Oncology Letters 19 (4): 3101–3110. doi:10.3892/ol.2020.11429. ISSN 1792-1074. PMC 7074170. PMID 32256810. https://pubmed.ncbi.nlm.nih.gov/32256810. 
  60. ^ Schwab, Marisa E.; Song, Hanbing; Mattis, Aras; Phelps, Andrew; Vu, Lan T.; Huang, Franklin W.; Nijagal, Amar (2020-03-24). “De novo somatic mutations and KRAS amplification are associated with cholangiocarcinoma in a patient with a history of choledochal cyst”. Journal of Pediatric Surgery. doi:10.1016/j.jpedsurg.2020.03.008. ISSN 1531-5037. PMID 32295706. https://pubmed.ncbi.nlm.nih.gov/32295706. 
  61. ^ Juratli, Tareq A.; McCabe, Devin; Nayyar, Naema; Williams, Erik A.; Silverman, Ian M.; Tummala, Shilpa S.; Fink, Alexandria L.; Baig, Aymen et al. (11 2018). “DMD genomic deletions characterize a subset of progressive/higher-grade meningiomas with poor outcome”. Acta Neuropathologica 136 (5): 779–792. doi:10.1007/s00401-018-1899-7. ISSN 1432-0533. PMID 30123936. https://pubmed.ncbi.nlm.nih.gov/30123936. 
  62. ^ Majd, Nazanin K.; Metrus, Nicolas R.; Santos-Pinheiro, Fernando; Trevino, Christopher R.; Fuller, Gregory N.; Huse, Jason T.; Chung, Caroline; Ketonen, Leena et al. (02 2019). “RBM10 truncation in astroblastoma in a patient with history of mandibular ameloblastoma: A case report”. Cancer Genetics 231-232: 41–45. doi:10.1016/j.cancergen.2019.01.001. ISSN 2210-7762. PMID 30803556. https://pubmed.ncbi.nlm.nih.gov/30803556. 
  63. ^ Loiselle, Julie J.; Sutherland, Leslie C. (05 2018). “RBM10: Harmful or helpful-many factors to consider”. Journal of Cellular Biochemistry 119 (5): 3809–3818. doi:10.1002/jcb.26644. ISSN 1097-4644. PMC 5901003. PMID 29274279. https://pubmed.ncbi.nlm.nih.gov/29274279. 
  64. ^ Misquitta-Ali, Christine M.; Cheng, Edith; O'Hanlon, Dave; Liu, Ni; McGlade, C. Jane; Tsao, Ming Sound; Blencowe, Benjamin J. (2011-01). “Global profiling and molecular characterization of alternative splicing events misregulated in lung cancer”. Molecular and Cellular Biology 31 (1): 138–150. doi:10.1128/MCB.00709-10. ISSN 1098-5549. PMC 3019846. PMID 21041478. https://pubmed.ncbi.nlm.nih.gov/21041478. 
  65. ^ a b Hernández, Jordi; Bechara, Elias; Schlesinger, Doerte; Delgado, Javier; Serrano, Luis; Valcárcel, Juan (2016). “Tumor suppressor properties of the splicing regulatory factor RBM10”. RNA biology 13 (4): 466–472. doi:10.1080/15476286.2016.1144004. ISSN 1555-8584. PMC 4841610. PMID 26853560. https://pubmed.ncbi.nlm.nih.gov/26853560. 
  66. ^ a b c Majd, Nazanin K.; Metrus, Nicolas R.; Santos-Pinheiro, Fernando; Trevino, Christopher R.; Fuller, Gregory N.; Huse, Jason T.; Chung, Caroline; Ketonen, Leena et al. (02 2019). “RBM10 truncation in astroblastoma in a patient with history of mandibular ameloblastoma: A case report”. Cancer Genetics 231-232: 41–45. doi:10.1016/j.cancergen.2019.01.001. ISSN 2210-7762. PMID 30803556. https://pubmed.ncbi.nlm.nih.gov/30803556. 
  67. ^ a b Han, Li-Ping; Wang, Cun-Ping; Han, Si-Lin (2018-10). “Overexpression of RBM10 induces osteosarcoma cell apoptosis and inhibits cell proliferation and migration”. Medecine Sciences: M/S 34 Focus issue F1: 81–86. doi:10.1051/medsci/201834f114. ISSN 1958-5381. PMID 30403180. https://pubmed.ncbi.nlm.nih.gov/30403180. 
  68. ^ Jin, Xin; Di, Xin; Wang, Ruimin; Ma, He; Tian, Chang; Zhao, Min; Cong, Shan; Liu, Jiaying et al. (06 2019). “RBM10 inhibits cell proliferation of lung adenocarcinoma via RAP1/AKT/CREB signalling pathway”. Journal of Cellular and Molecular Medicine 23 (6): 3897–3904. doi:10.1111/jcmm.14263. ISSN 1582-4934. PMC 6533519. PMID 30955253. https://pubmed.ncbi.nlm.nih.gov/30955253. 
  69. ^ Sutherland, Leslie C.; Rintala-Maki, Nina D.; White, Ryan D.; Morin, Cory D. (2005-01-01). “RNA binding motif (RBM) proteins: a novel family of apoptosis modulators?”. Journal of Cellular Biochemistry 94 (1): 5–24. doi:10.1002/jcb.20204. ISSN 0730-2312. PMID 15514923. https://pubmed.ncbi.nlm.nih.gov/15514923. 
  70. ^ Wang, Ke; Bacon, Mackensey L.; Tessier, Julie J.; Rintala-Maki, Nina D.; Tang, Vanessa; Sutherland, Leslie C. (2012). “RBM10 Modulates Apoptosis and Influences TNF-α Gene Expression”. Journal of Cell Death 5: 1–19. doi:10.4137/JCD.S9073. ISSN 1179-0660. PMC 4583097. PMID 26446321. https://pubmed.ncbi.nlm.nih.gov/26446321. 
  71. ^ Sun, Xiuna; Jia, Mengqi; Sun, Wei; Feng, Lu; Gu, Chundong; Wu, Taihua (2019-02). “Functional role of RBM10 in lung adenocarcinoma proliferation”. International Journal of Oncology 54 (2): 467–478. doi:10.3892/ijo.2018.4643. ISSN 1791-2423. PMC 6317669. PMID 30483773. https://pubmed.ncbi.nlm.nih.gov/30483773. 
  72. ^ Balachandran, Vinod P.; Łuksza, Marta; Zhao, Julia N.; Makarov, Vladimir; Moral, John Alec; Remark, Romain; Herbst, Brian; Askan, Gokce et al. (11 23, 2017). “Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer”. Nature 551 (7681): 512–516. doi:10.1038/nature24462. ISSN 1476-4687. PMC 6145146. PMID 29132146. https://pubmed.ncbi.nlm.nih.gov/29132146. 
  73. ^ Siegel, Rebecca L.; Miller, Kimberly D.; Jemal, Ahmedin (01 2018). “Cancer statistics, 2018”. CA: a cancer journal for clinicians 68 (1): 7–30. doi:10.3322/caac.21442. ISSN 1542-4863. PMID 29313949. https://pubmed.ncbi.nlm.nih.gov/29313949. 
  74. ^ Mourtada-Maarabouni, Mirna; Williams, Gwyn T. (2002-07-04). “RBM5/LUCA-15--tumour suppression by control of apoptosis and the cell cycle?”. TheScientificWorldJournal 2: 1885–1890. doi:10.1100/tsw.2002.859. ISSN 1537-744X. PMC 6009235. PMID 12920317. https://pubmed.ncbi.nlm.nih.gov/12920317. 
  75. ^ Oh, Juliana J.; Razfar, Ali; Delgado, Idolina; Reed, Rebecca A.; Malkina, Anna; Boctor, Baher; Slamon, Dennis J. (2006-04-01). “3p21.3 tumor suppressor gene H37/Luca15/RBM5 inhibits growth of human lung cancer cells through cell cycle arrest and apoptosis”. Cancer Research 66 (7): 3419–3427. doi:10.1158/0008-5472.CAN-05-1667. ISSN 0008-5472. PMID 16585163. https://pubmed.ncbi.nlm.nih.gov/16585163. 
  76. ^ Fushimi, Kazuo; Ray, Payal; Kar, Amar; Wang, Lei; Sutherland, Leslie C.; Wu, Jane Y. (2008-10-14). “Up-regulation of the proapoptotic caspase 2 splicing isoform by a candidate tumor suppressor, RBM5”. Proceedings of the National Academy of Sciences of the United States of America 105 (41): 15708–15713. doi:10.1073/pnas.0805569105. ISSN 1091-6490. PMC 2572934. PMID 18840686. https://pubmed.ncbi.nlm.nih.gov/18840686. 
  77. ^ Bonnal, Sophie; Martínez, Concepción; Förch, Patrik; Bachi, Angela; Wilm, Matthias; Valcárcel, Juan (2008-10-10). “RBM5/Luca-15/H37 regulates Fas alternative splice site pairing after exon definition”. Molecular Cell 32 (1): 81–95. doi:10.1016/j.molcel.2008.08.008. ISSN 1097-4164. PMID 18851835. https://pubmed.ncbi.nlm.nih.gov/18851835. 
  78. ^ Sutherland, Leslie C.; Wang, Ke; Robinson, Andrew G. (2010-03). “RBM5 as a putative tumor suppressor gene for lung cancer”. Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer 5 (3): 294–298. doi:10.1097/JTO.0b013e3181c6e330. ISSN 1556-1380. PMID 20186023. https://pubmed.ncbi.nlm.nih.gov/20186023. 
  79. ^ Jamsai, Duangporn; Watkins, D. Neil; O'Connor, Anne E.; Merriner, D. Jo; Gursoy, Selen; Bird, Anthony D.; Kumar, Beena; Miller, Alistair et al. (11 24, 2017). “In vivo evidence that RBM5 is a tumour suppressor in the lung”. Scientific Reports 7 (1): 16323. doi:10.1038/s41598-017-15874-9. ISSN 2045-2322. PMC 5701194. PMID 29176597. https://pubmed.ncbi.nlm.nih.gov/29176597. 
  80. ^ Wang, Qiwei; Wang, Fang; Zhong, Waisheng; Ling, Hang; Wang, Jixuan; Cui, Jie; Xie, Tao; Wen, Senli et al. (2019-05-20). “RNA-binding protein RBM6 as a tumor suppressor gene represses the growth and progression in laryngocarcinoma”. Gene 697: 26–34. doi:10.1016/j.gene.2019.02.025. ISSN 1879-0038. PMID 30772516. https://pubmed.ncbi.nlm.nih.gov/30772516. 
  81. ^ Deckert, Jochen; Hartmuth, Klaus; Boehringer, Daniel; Behzadnia, Nastaran; Will, Cindy L.; Kastner, Berthold; Stark, Holger; Urlaub, Henning et al. (2006-07). “Protein composition and electron microscopy structure of affinity-purified human spliceosomal B complexes isolated under physiological conditions”. Molecular and Cellular Biology 26 (14): 5528–5543. doi:10.1128/MCB.00582-06. ISSN 0270-7306. PMC 1592722. PMID 16809785. https://pubmed.ncbi.nlm.nih.gov/16809785. 
  82. ^ Papasaikas, Panagiotis; Tejedor, J. Ramón; Vigevani, Luisa; Valcárcel, Juan (2015-01-08). “Functional splicing network reveals extensive regulatory potential of the core spliceosomal machinery”. Molecular Cell 57 (1): 7–22. doi:10.1016/j.molcel.2014.10.030. ISSN 1097-4164. PMID 25482510. https://pubmed.ncbi.nlm.nih.gov/25482510. 
  83. ^ Ule, Jernej; Blencowe, Benjamin J. (10 17, 2019). “Alternative Splicing Regulatory Networks: Functions, Mechanisms, and Evolution”. Molecular Cell 76 (2): 329–345. doi:10.1016/j.molcel.2019.09.017. ISSN 1097-4164. PMID 31626751. https://pubmed.ncbi.nlm.nih.gov/31626751. 

[続きの解説]

「RBM10」の続きの解説一覧

急上昇のことば

月に吠える (萩原朔太郎の詩集)
忸怩たる思い
after . .
暴徒化
頁
英和和英テキスト翻訳>> Weblio翻訳
英語⇒日本語日本語⇒英語
  
  •  RBM10のページへのリンク

辞書ショートカット

カテゴリ一覧

全て

＋ ビジネス

＋ 業界用語

＋ コンピュータ

＋ 電車

＋ 自動車・バイク

＋ 船

＋ 工学

＋ 建築・不動産

＋ 学問

＋ 文化

＋ 生活

＋ ヘルスケア

＋ 趣味

＋ スポーツ

＋ 生物

＋ 食品

＋ 人名

＋ 方言

＋ 辞書・百科事典

すべての辞書の索引

あいうえお
かきくけこ
さしすせそ
たちつてと
なにぬねの
はひふへほ
まみむめも
やゆよ
らりるれろ
わをん
がぎぐげご
ざじずぜぞ
だぢづでど
ばびぶべぼ
ぱぴぷぺぽ
ＡＢＣＤＥ
ＦＧＨＩＪ
ＫＬＭＮＯ
ＰＱＲＳＴ
ＵＶＷＸＹ
Ｚ
１２３４５
６７８９０
記号

Weblioのサービス

「RBM10」の関連用語

1
調節
ウィキペディア小見出し辞書
100% |||||

2
パラログとスプライシングネットワーク
ウィキペディア小見出し辞書
100% |||||

3
臨床的意義
ウィキペディア小見出し辞書
78% |||||

4
遺伝子とタンパク質
ウィキペディア小見出し辞書
78% |||||

5
がんにおける役割
ウィキペディア小見出し辞書
16% |||||

RBM10のお隣キーワード

RBE2

RBF

RBG 最強の85才

RBI

RBKデイリー

RBM

RBM10

RBMK-1000

RBMT

RBS

RBS 70

RBS-15

RBT

検索ランキング

   

 英語⇒日本語
日本語⇒英語		    


RBM10のページの著作権
Weblio 辞書 情報提供元は 参加元一覧 にて確認できます。

   
ウィキペディアウィキペディア
All text is available under the terms of the GNU Free Documentation License.
この記事は、ウィキペディアのRBM10 (改訂履歴)の記事を複製、再配布したものにあたり、GNU Free Documentation Licenseというライセンスの下で提供されています。 Weblio辞書に掲載されているウィキペディアの記事も、全てGNU Free Documentation Licenseの元に提供されております。

©2024 GRAS Group, Inc.RSS